Vinorelbine With Trastuzumab Emtansine in Pre-Treated HER2-Positive Metastatic Breast Cancer

NCT02658084 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Terminated due to low accrual and toxicity concerns.

Conditions

Breast Cancer
Metastatic Breast Cancer

Interventions

DRUG: Vinorelbine
DRUG: Trastuzumab Emtansine

Sponsor

University of Miami

Collaborators

[object Object]